Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide
2. 3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)-propionamide
3. S-4 Cpd
1. 401900-40-1
2. Gtx-007
3. (2s)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
4. Gtx007
5. S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
6. 7ut2hah49h
7. Chembl125236
8. Propanamide, 3-(4-(acetylamino)phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)-, (2s)-
9. Andarine (gtx-007)
10. (2s)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
11. (s)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)propanamide
12. S-4
13. S-4 Cpd
14. Andarine;s4
15. Unii-7ut2hah49h
16. (s)-andarine
17. H_166_andarine_s4
18. Andarine - Gtx-007
19. Sarm S-4
20. Mls006010738
21. Gtx 007
22. Nonsteroidal Ar Ligand, S-6
23. Gtpl7849
24. Schembl2689756
25. Bdbm18665
26. Chebi:94760
27. Dtxsid40193187
28. Ex-a724
29. 3b68
30. Bcpp000400
31. Hms3654m08
32. Amy38109
33. Bcp01832
34. Zinc3991693
35. Mfcd09027386
36. S1140
37. Akos005145785
38. Akos015841082
39. Bmc185567 S-4
40. Bcp9000302
41. Ccg-264833
42. Cs-0160
43. Db07423
44. Ncgc00263150-01
45. Ncgc00263150-02
46. Ncgc00263150-04
47. Ac-26920
48. As-19581
49. Hy-12023
50. N-[4-nitro-3-(trifluoromethyl)phenyl]-(2s)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methylpropanamide
51. Smr004701697
52. Sw219160-1
53. 900n401
54. J-523346
55. Q4753617
56. Brd-k82164249-001-02-7
57. (2s)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
58. (s)-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide
59. (s)-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide, Analytical Standard
60. 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide
61. 3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)-propionamide
62. B68
63. N-[4-ntro-3-(trfluoromethyl)phenyl]-(2s)-3-[4-(acetylamno)phenoxy]-2-hydroxy-2-methylpropanamde
64. Propanamide, 3-?[4-?(acetylamino)?phenoxy]?-?2-?hydroxy-?2-?methyl-?n-?[4-?nitro-?3-?(trifluoromethyl)?phenyl]?-?, (2s)?-
| Molecular Weight | 441.4 g/mol |
|---|---|
| Molecular Formula | C19H18F3N3O6 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 441.11476979 g/mol |
| Monoisotopic Mass | 441.11476979 g/mol |
| Topological Polar Surface Area | 134 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 663 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Andarine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Andarine, including repackagers and relabelers. The FDA regulates Andarine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Andarine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Andarine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Andarine supplier is an individual or a company that provides Andarine active pharmaceutical ingredient (API) or Andarine finished formulations upon request. The Andarine suppliers may include Andarine API manufacturers, exporters, distributors and traders.
click here to find a list of Andarine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Andarine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Andarine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Andarine GMP manufacturer or Andarine GMP API supplier for your needs.
A Andarine CoA (Certificate of Analysis) is a formal document that attests to Andarine's compliance with Andarine specifications and serves as a tool for batch-level quality control.
Andarine CoA mostly includes findings from lab analyses of a specific batch. For each Andarine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Andarine may be tested according to a variety of international standards, such as European Pharmacopoeia (Andarine EP), Andarine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Andarine USP).
LOOKING FOR A SUPPLIER?
